Published in Br J Cancer on October 18, 2011
Downregulation of myosin VI reduced cell growth and increased apoptosis in human colorectal cancer. Acta Biochim Biophys Sin (Shanghai) (2016) 0.75
Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88
Screening and prostate-cancer mortality in a randomized European study. N Engl J Med (2009) 35.94
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med (2004) 15.10
Delineation of prognostic biomarkers in prostate cancer. Nature (2001) 12.25
Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics (2006) 10.83
Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer (2010) 10.61
Integrative molecular concept modeling of prostate cancer progression. Nat Genet (2006) 8.49
Outcome signature genes in breast cancer: is there a unique set? Bioinformatics (2004) 7.96
alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA (2002) 5.07
Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res (2001) 4.51
Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res (2001) 3.45
Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res (2002) 2.84
Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res (2006) 2.40
Molecular cloning and characterization of a human adenocarcinoma/epithelial cell surface antigen complementary DNA. Cancer Res (1989) 1.62
Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia. J Urol (1999) 1.35
Many accurate small-discriminatory feature subsets exist in microarray transcript data: biomarker discovery. BMC Bioinformatics (2005) 1.28
Differential expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and normal prostate. Am J Pathol (1996) 1.10
Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens. Hum Pathol (2004) 1.07
On the number of close-to-optimal feature sets. Cancer Inform (2007) 0.97
Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol (1998) 0.96
Co-regulation analysis of closely linked genes identifies a highly recurrent gain on chromosome 17q25.3 in prostate cancer. BMC Cancer (2008) 0.85
Discrimination and scoring using small sets of genes for two-sample microarray data. Math Biosci (2006) 0.82
Validation of cytokeratin 5/6 as an effective substitute for keratin 903 in the differentiation of benign from malignant glands in prostate needle biopsies. Histopathology (2002) 0.81
Breast stereotactic core biopsy washings: abundant cell samples from clinically occult lesions for flow cytometric DNA analysis. Invest Radiol (1998) 0.80
Needle biopsy of the liver for the diagnosis of nonneoplastic liver diseases. Acta Cytol (1985) 0.77
Tumor marker measurements of cells in a fine needle used for aspiration cytology. Anal Quant Cytol Histol (2004) 0.77
Stereotactic core biopsy breast and blood cell by-products: a source of material for molecular genetics research--initial experience. Radiology (2001) 0.77
MONSSTER: a method for folding globular proteins with a small number of distance restraints. J Mol Biol (1997) 2.37
Neutrophil depletion during Toxoplasma gondii infection leads to impaired immunity and lethal systemic pathology. Infect Immun (2001) 1.92
A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum. Int J Cancer (1983) 1.87
Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon. J Exp Med (1984) 1.81
Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology (1997) 1.80
Adenoid cystic carcinoma of the breast: mammographic appearance and pathologic correlation. AJR Am J Roentgenol (1998) 1.73
CAFASP2: the second critical assessment of fully automated structure prediction methods. Proteins (2001) 1.50
Pigmentation-associated glycoprotein of human melanomas and melanocytes: definition with a mouse monoclonal antibody. J Invest Dermatol (1985) 1.39
PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res (1994) 1.34
Role of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cells. Mol Cell Biol (1998) 1.30
Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse. Br J Cancer (2005) 1.26
Immunohistochemical analysis of nerve growth factor receptor expression in normal and malignant human tissues. J Histochem Cytochem (1988) 1.19
Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res (1994) 1.16
Monoclonal antibody to an intracellular antigen images human melanoma transplants in nu/nu mice. Proc Natl Acad Sci U S A (1987) 1.15
Toxoplasma gondii and Schistosoma mansoni synergize to promote hepatocyte dysfunction associated with high levels of plasma TNF-alpha and early death in C57BL/6 mice. J Immunol (1999) 1.15
The 1965 eruption of taal volcano. Science (1966) 1.13
Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma. J Pathol (1996) 1.13
Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1. J Urol (1996) 1.12
PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks. Oncogene (2001) 1.11
Acute pancreatitis after renal transplantation. Br J Surg (1989) 1.08
Regulation of mitotic exit by the RNF8 ubiquitin ligase. Oncogene (2007) 1.07
Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma. J Urol (1994) 1.05
cdc25 cell cycle-activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas. Cancer Res (1998) 1.03
Idiopathic chondrolysis of the hip: long-term evolution. J Pediatr Orthop (1999) 1.03
cdc25a and the splicing variant cdc25b2, but not cdc25B1, -B3 or -C, are over-expressed in aggressive human non-Hodgkin's lymphomas. Int J Cancer (2000) 1.01
Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma. Br J Cancer (2000) 1.00
Interleukin-12 promotes pathologic liver changes and death in mice coinfected with Schistosoma mansoni and Toxoplasma gondii. Infect Immun (2001) 1.00
Comparative binding energy analysis of HIV-1 protease inhibitors: incorporation of solvent effects and validation as a powerful tool in receptor-based drug design. J Med Chem (1998) 1.00
Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status. J Pathol (1997) 0.99
Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J Pathol (1998) 0.99
Normothermic recirculation reduces primary graft dysfunction of kidneys obtained from non-heart-beating donors. Transpl Int (2000) 0.97
Specificity analysis of human monoclonal antibodies reactive with cell surface and intracellular antigens. Proc Natl Acad Sci U S A (1986) 0.97
Autoradiographic distribution studies on 14C-Metronidazole in mice. Proc West Pharmacol Soc (1968) 0.96
c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin's lymphomas. Leukemia (1999) 0.96
Anti-golgi complex autoantibodies in a patient with Sjögren syndrome and lymphoma. Clin Exp Immunol (1982) 0.96
p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma. J Pathol (1998) 0.96
An aminoacyl tRNA synthetase whose sequence fits into neither of the two known classes. Nature (2001) 0.95
Evaluation of docking functions for protein-ligand docking. J Med Chem (2001) 0.95
Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon. Nucleic Acids Res (2010) 0.94
Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer. Br J Cancer (2009) 0.93
Role of a nonnative interaction in the folding of the protein G B1 domain as inferred from the conformational analysis of the alpha-helix fragment. Fold Des (1997) 0.93
Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinoma. Clin Cancer Res (1996) 0.93
Differential expression of cdc25 cell-cycle-activating phosphatases in human colorectal carcinoma. Lab Invest (2001) 0.92
Antioxidant patterns (superoxide dismutase, glutathione reductase, and glutathione peroxidase) in kidneys from non-heart-beating-donors: experimental study. Transplant Proc (2007) 0.92
INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene. Am J Pathol (2000) 0.91
N-Ras induces alterations in Golgi complex architecture and in constitutive protein transport. J Cell Sci (1999) 0.89
Nephron-sparing surgery for renal tumor: a choice of treatment in an allograft kidney. Transplant Proc (2006) 0.89
Crystal structure of trbp111: a structure-specific tRNA-binding protein. EMBO J (2000) 0.88
Ki-ras gene mutations and absence of p53 gene mutations in spontaneous and urethane-induced early lung lesions in CBA/J mice. Mol Carcinog (1998) 0.88
p21WAF1/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx. J Pathol (1997) 0.88
Small bladder and multiple urethral recurrences after intravesical instillation of bacillus Calmette-Guerin for superficial transitional cell carcinoma of the bladder. J Urol (2001) 0.87
1H and 15N NMR assignment and solution structure of the SH3 domain of spectrin: comparison of unrefined and refined structure sets with the crystal structure. J Biomol NMR (1997) 0.87
Serum HER2 extracellular domain predicts an aggressive clinical outcome and biological PSA response in hormone-independent prostate cancer patients treated with docetaxel. Ann Oncol (2007) 0.87
Transposition of iliac vessels in implantation of right living donor kidneys. Transplant Proc (2012) 0.86
The subcellular binding of propranolol in rat heart. J Pharm Pharmacol (1967) 0.86
Extraskeletal Ewing's sarcoma metastatic to penis. Br J Urol (1992) 0.86
Middle-ear adenoma (MEA): a report of two cases, one with predominant "plasmacytoid' features. Histopathology (1997) 0.85
Protein disorder in the centrosome correlates with complexity in cell types number. Mol Biosyst (2011) 0.85
p16MTS1/CDK4I mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous cell carcinoma of the larynx. Oncogene (1997) 0.85
A molecular dynamics study of the bis-intercalation complexes of echinomycin with d(ACGT)2 and d(TCGA)2: rationale for sequence-specific Hoogsteen base pairing. J Med Chem (1993) 0.84
PET/CT with [18F] fluorodeoxyglucose in the assessment of metabolic response to neoadjuvant chemotherapy in locally advanced breast cancer. Q J Nucl Med Mol Imaging (2012) 0.83
Reduced protein models and their application to the protein folding problem. J Biomol Struct Dyn (1998) 0.83
Distribution and metabolism of 14C-metronidazole in mice. Arch Int Pharmacodyn Ther (1970) 0.83
Glycosyl phosphatidylinositol membrane anchoring of melanotransferrin (p97): apical compartmentalization in intestinal epithelial cells. J Cell Sci (1993) 0.83
Comparative binding energy analysis of the substrate specificity of haloalkane dehalogenase from Xanthobacter autotrophicus GJ10. Biochemistry (2001) 0.83
Natural radioactivity in Spanish soils. Health Phys (1994) 0.83
Complex renal transplant for vascular reasons. Transplant Proc (1992) 0.83
Synthetic nanopores with fixed charges: an electrodiffusion model for ionic transport. Phys Rev E Stat Nonlin Soft Matter Phys (2003) 0.82
Endourological management is better in early-onset ureteral stenosis in kidney transplantation. Transplant Proc (2005) 0.82
p53 expression predicts progression and poor survival in T1 bladder tumours. Eur Urol (2000) 0.81
[Large series of 114 cases with long-term follow-up of upper urinary tract urothelial tumors]. Actas Urol Esp (2010) 0.81
Natural gamma radiation map (MARNA) and indoor radon levels in Spain. Environ Int (2004) 0.81
Third and fourth kidney transplant: still a reasonable option. Transplant Proc (2010) 0.81
Numeric alterations in chromosomes 7 and 8 detected by fluorescent in situ hybridization correlate with high-grade localized prostate cancer. Eur Urol (1998) 0.81
Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging. Anticancer Res (2006) 0.80
The Alpha Project: a model system for systems biology research. IET Syst Biol (2008) 0.80
Hypertension, dyslipidemia and overweight are related to lower testosterone levels in a cohort of men undergoing prostate biopsy. Int J Impot Res (2012) 0.80
Interactions between hemodynamics and pharmacology in kidney transplantation. Transplant Proc (2011) 0.79
Potentiation of oncogenic N-ras-induced neurite outgrowth and ornithine decarboxylase activity by phorbol dibutyrate and protein kinase inhibitor H-8. J Cell Physiol (1990) 0.79
Assessment of solvation effects on calculated binding affinity differences: trypsin inhibition by flavonoids as a model system for congeneric series. J Med Chem (1997) 0.79
Risk factors for cardiovascular disease after renal transplantation. Transplant Proc (2003) 0.79
Significance of cytomegalovirus infection in renal transplantation. Transplant Proc (2003) 0.79
[Pioneer experience in Spain with LSSS nephrectomy in living donor]. Actas Urol Esp (2011) 0.79
Tropical sprue and malnutrition in West Bengal. 3. Biochemical characteristics of bile salts in the small intestine. Am J Clin Nutr (1970) 0.78
Radioactivity in Spanish spas. Sci Total Environ (1995) 0.78
Experimental study of the cellular energy charge in pig kidney transplants from non-heart-beating donors. Transplant Proc (1999) 0.78
Homology modeling of the Abl-SH3 domain. Proteins (1994) 0.78
[Living donor kidney transplantation: helical CT evaluation of candidates]. Actas Urol Esp (2006) 0.78
[Erectile dysfunction and its severity are related to the number of cardiovascular risk factors]. Actas Urol Esp (2012) 0.78
Undetectable prostate specific antigen in disseminated prostate cancer. J Urol (2001) 0.78
Assignment of human nerve growth factor receptor gene to chromosome 17 and regulation of receptor expression in somatic cell hybrids. Somat Cell Mol Genet (1986) 0.78
Transient induction of heme oxygenase after cortical stab wound injury. Brain Res Mol Brain Res (1996) 0.77
Tacrolimus in induction immunosuppressive treatment in renal transplantation: comparison with cyclosporine. Transplant Proc (2003) 0.77
Critical assessment of OmpF channel selectivity: merging information from different experimental protocols. J Phys Condens Matter (2010) 0.77
Disregulation of p16MTS1/CDK4I protein and mRNA expression is associated with gene alterations in squamous-cell carcinoma of the larynx. Int J Cancer (1999) 0.77
High background radiation areas: the case of Villar de la Yegua village (Spain). Radiat Prot Dosimetry (2007) 0.77
Exogenous surfactant therapy for acute respiratory distress in infancy. Intensive Care Med (1996) 0.77